IMAB362

Results: 12



#Item
1

Microsoft WordGanymed IMAB362 Completion of Ph 2a in GEC_final

Add to Reading List

Source URL: www.ganymed-pharmaceuticals.com

- Date: 2015-02-04 05:14:59
    2Clinical medicine / Medicine / Cancer / RTT / Monoclonal antibodies / Antineoplastic drugs / Cancer treatments / IMAB362 / Chemotherapy / Ovarian cancer / Lung cancer / Treatment of cancer

    Press Release For Immediate Release June 5, 2016

    Add to Reading List

    Source URL: www.ganymed-pharmaceuticals.com

    Language: English - Date: 2016-06-05 08:04:51
    3Medicine / Immunology / Monoclonal antibodies / Clinical medicine / Biology / Immune system / Pathology / Biotechnology / IMAB362 / Cancer / Monoclonal antibody therapy / Antibody

    Press release Clinical Phase I Results of GANYMED’s iMAB362 Antibody Demonstrate Excellent Safety Mainz, Germany, August 04, A clinical first-in-human Phase I multi center study with GANYMED’s monoclonal anti

    Add to Reading List

    Source URL: www.ganymed-pharmaceuticals.com

    Language: English - Date: 2015-02-04 05:15:07
    4RTT / Monoclonal antibodies / IMAB362 / Medicine / Clinical medicine / Treatment of cancer / Cancer / Health / Pancreatic cancer / Seattle Genetics

    Press Release For Immediate Release October 21, 2013

    Add to Reading List

    Source URL: www.ganymed-pharmaceuticals.com

    Language: English - Date: 2015-02-04 05:14:56
    5

    Pressemitteilung Studie: Ganymeds Antikörper IMAB362 verlängert Überlebenszeit von Magenkrebspatienten - Überlebenszeit von Patienten mit höchsten Claudin18.2-Werten fast verdoppelt - Mainzer Ganymed Pharmaceuticals

    Add to Reading List

    Source URL: www.ganymed-pharmaceuticals.com

    Language: German - Date: 2016-06-05 08:04:51
      6Medicine / Clinical medicine / Health care / Immunology / Pathology / Immune system / Monoclonal antibodies / Immunohistochemistry / Antibody / Cancer / IMAB362 / Racotumomab

      GANYMED lead antibodies show excellent efficacy and safety in mouse tumor models Mainz, Germany – April 5, 2006 – GANYMED Pharmaceuticals AG announced today that several monoclonal lead antibodies directed against th

      Add to Reading List

      Source URL: www.ganymed-pharmaceuticals.com

      Language: English - Date: 2015-02-04 05:14:57
      7Medicine / Monoclonal antibodies / IMAB362 / Clinical medicine / Health / Antibody / Cancer / Ganymed

      Press release GANYMED closes EUR 65 M Financing Round November 18, 2008, Mainz - GANYMED Pharmaceuticals AG today announced the closing of a EUR 65 M financing round. The round was led by ATS Beteiligungsverwaltung GmbH

      Add to Reading List

      Source URL: www.ganymed-pharmaceuticals.com

      Language: English - Date: 2015-02-04 05:14:59
      8Medicine / Clinical medicine / RTT / Cancer / Monoclonal antibodies / IMAB362 / Antineoplastic drugs / Cancer treatments / Oncology / Treatment of cancer / Chemotherapy / Ovarian cancer

      Press Release For Immediate Release July 22, 2014

      Add to Reading List

      Source URL: www.ganymed-pharmaceuticals.com

      Language: English - Date: 2015-02-04 05:14:58
      9Monoclonal antibodies / IMAB362 / Cancer / Health

        Press Release For Immediate Release

      Add to Reading List

      Source URL: www.ganymed-pharmaceuticals.com

      Language: English - Date: 2016-05-17 04:09:28
      10IMAB362

      International Press Release BioNTech AG and Ganymed Pharmaceuticals AG Open New Research Headquarters in Mainz, Germany Mainz, Germany, October 1, BioNTech AG and Ganymed Pharmaceuticals AG, two premier German bi

      Add to Reading List

      Source URL: www.ganymed-pharmaceuticals.com

      Language: English - Date: 2015-02-04 05:14:58
        UPDATE